Polymeric Inserts Containing Eudragit<sup>®</sup> L100 Nanoparticle for Improved Ocular Delivery of Azithromycin
Polymeric inserts containing azithromycin-loaded Eudragit<sup>®</sup> L100 nanoparticles were developed to sustain the drug release and enhance its ocular performance. The solvent diffusion technique was employed to prepare nanoparticles. The developed nanoparticles (NPs) were fully char...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/8/11/466 |
id |
doaj-5d8c2b50e6384b029cd36e808e8b10ba |
---|---|
record_format |
Article |
spelling |
doaj-5d8c2b50e6384b029cd36e808e8b10ba2020-11-25T03:58:31ZengMDPI AGBiomedicines2227-90592020-10-01846646610.3390/biomedicines8110466Polymeric Inserts Containing Eudragit<sup>®</sup> L100 Nanoparticle for Improved Ocular Delivery of AzithromycinShiva Taghe0Shahla Mirzaeei1Raid G. Alany2Ali Nokhodchi3Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6714415153, IranPharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6714415153, IranDrug Discovery, Delivery and Patient Care (DDDPC), School of Life Sciences, Pharmacy and Chemistry, Kingston University, London KT1 2EE, UKPharmaceutics Research Laboratory, School of Life Sciences, University of Sussex, Brighton BN1 9QJ, UKPolymeric inserts containing azithromycin-loaded Eudragit<sup>®</sup> L100 nanoparticles were developed to sustain the drug release and enhance its ocular performance. The solvent diffusion technique was employed to prepare nanoparticles. The developed nanoparticles (NPs) were fully characterized and investigated. The solvent casting method was used to prepare azithromycin ocular inserts (azithromycin, AZM film) by adding hydroxypropyl methylcellulose (HPMC) or hydroxyethyl cellulose (HEC) solutions after the incorporation of AZM-loaded Eudragit<sup>®</sup> L100 nanoparticles into plasticized PVA (polyvinyl alcohol) solutions. The optimized nanoparticles had a particle size of 78.06 ± 2.3 nm, zeta potential around −2.45 ± 0.69 mV, polydispersity index around 0.179 ± 0.007, and entrapment efficiency 62.167 ± 0.07%. The prepared inserts exhibited an antibacterial effect on <i>Staphylococcus aureus</i> and <i>Escherichia coli</i> cultures. The inserts containing AZM-loaded nanoparticles showed a burst release during the initial hours, followed by a sustained drug release pattern. Higher cumulative corneal permeations from AZM films were observed for the optimized formulation compared to the drug solution in the ex-vivo trans-corneal study. In comparison to the AZM solution, the inserts significantly prolonged the release of AZM in rabbit eyes (121 h). The mucoadhesive inserts containing azithromycin-loaded Eudragit<sup>®</sup> L100 nanoparticles offer a promising approach for the ocular delivery of azithromycin (antibacterial and anti-inflammatory) to treat ocular infections that require a prolonged drug delivery.https://www.mdpi.com/2227-9059/8/11/466Azithromycincontrolled drug deliveryEudragit<sup>®</sup> L100 nanoparticlesmucoadhesive filmsocular drug delivery |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shiva Taghe Shahla Mirzaeei Raid G. Alany Ali Nokhodchi |
spellingShingle |
Shiva Taghe Shahla Mirzaeei Raid G. Alany Ali Nokhodchi Polymeric Inserts Containing Eudragit<sup>®</sup> L100 Nanoparticle for Improved Ocular Delivery of Azithromycin Biomedicines Azithromycin controlled drug delivery Eudragit<sup>®</sup> L100 nanoparticles mucoadhesive films ocular drug delivery |
author_facet |
Shiva Taghe Shahla Mirzaeei Raid G. Alany Ali Nokhodchi |
author_sort |
Shiva Taghe |
title |
Polymeric Inserts Containing Eudragit<sup>®</sup> L100 Nanoparticle for Improved Ocular Delivery of Azithromycin |
title_short |
Polymeric Inserts Containing Eudragit<sup>®</sup> L100 Nanoparticle for Improved Ocular Delivery of Azithromycin |
title_full |
Polymeric Inserts Containing Eudragit<sup>®</sup> L100 Nanoparticle for Improved Ocular Delivery of Azithromycin |
title_fullStr |
Polymeric Inserts Containing Eudragit<sup>®</sup> L100 Nanoparticle for Improved Ocular Delivery of Azithromycin |
title_full_unstemmed |
Polymeric Inserts Containing Eudragit<sup>®</sup> L100 Nanoparticle for Improved Ocular Delivery of Azithromycin |
title_sort |
polymeric inserts containing eudragit<sup>®</sup> l100 nanoparticle for improved ocular delivery of azithromycin |
publisher |
MDPI AG |
series |
Biomedicines |
issn |
2227-9059 |
publishDate |
2020-10-01 |
description |
Polymeric inserts containing azithromycin-loaded Eudragit<sup>®</sup> L100 nanoparticles were developed to sustain the drug release and enhance its ocular performance. The solvent diffusion technique was employed to prepare nanoparticles. The developed nanoparticles (NPs) were fully characterized and investigated. The solvent casting method was used to prepare azithromycin ocular inserts (azithromycin, AZM film) by adding hydroxypropyl methylcellulose (HPMC) or hydroxyethyl cellulose (HEC) solutions after the incorporation of AZM-loaded Eudragit<sup>®</sup> L100 nanoparticles into plasticized PVA (polyvinyl alcohol) solutions. The optimized nanoparticles had a particle size of 78.06 ± 2.3 nm, zeta potential around −2.45 ± 0.69 mV, polydispersity index around 0.179 ± 0.007, and entrapment efficiency 62.167 ± 0.07%. The prepared inserts exhibited an antibacterial effect on <i>Staphylococcus aureus</i> and <i>Escherichia coli</i> cultures. The inserts containing AZM-loaded nanoparticles showed a burst release during the initial hours, followed by a sustained drug release pattern. Higher cumulative corneal permeations from AZM films were observed for the optimized formulation compared to the drug solution in the ex-vivo trans-corneal study. In comparison to the AZM solution, the inserts significantly prolonged the release of AZM in rabbit eyes (121 h). The mucoadhesive inserts containing azithromycin-loaded Eudragit<sup>®</sup> L100 nanoparticles offer a promising approach for the ocular delivery of azithromycin (antibacterial and anti-inflammatory) to treat ocular infections that require a prolonged drug delivery. |
topic |
Azithromycin controlled drug delivery Eudragit<sup>®</sup> L100 nanoparticles mucoadhesive films ocular drug delivery |
url |
https://www.mdpi.com/2227-9059/8/11/466 |
work_keys_str_mv |
AT shivataghe polymericinsertscontainingeudragitsupsupl100nanoparticleforimprovedoculardeliveryofazithromycin AT shahlamirzaeei polymericinsertscontainingeudragitsupsupl100nanoparticleforimprovedoculardeliveryofazithromycin AT raidgalany polymericinsertscontainingeudragitsupsupl100nanoparticleforimprovedoculardeliveryofazithromycin AT alinokhodchi polymericinsertscontainingeudragitsupsupl100nanoparticleforimprovedoculardeliveryofazithromycin |
_version_ |
1724456845152616448 |